Summary
This guidance is based on the NEPTUNE Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances made by the Novel Psychoactive Treatment: UK Network Project, hosted by the Central and Northwest London NHS Foundation Trust.
It has been supported and funded by the EMCDDA, through the EU4Monitoring Drugs (EU4MD) project, funded by the European Union, and the EU-ACT, EU Action Against Drugs and Organised Crime, Project. EU-ACT is a project funded by the European Union and implemented by FIIAPP, International and Ibero- American Foundation for Administration and Public Policies.
The NEPTUNE Guidance on the Clinical Management of Acute and Chronic Harms of Club Drugs and Novel Psychoactive Substances is based on a comprehensive review of the clinical and research evidence available up to June 2020. It has been made by Professor Owen Bowden-Jones and Doctor Dima Abdulrahim, from the NEPTUNE Project.
This Georgian language version has been proofread by staff of the Centre for Mental Health and Prevention of Addiction (CMHPA), Georgia.
Download as PDF
NEPTUNE NPS Guidance
PDF files are made available as a convenience. In cases where the EMCDDA is not the originator of the document, please be aware that any PDFs available on this page may not be authoritative or there may be more recent versions available. While we make every effort to ensure that these files are definitive, before using or citing them, we recommend that you consult the publisher's website or contact the author(s) to check for more recent versions.
- Open access
- Georgia
- Ukraine
- Georgian
- Ukrainian